Provided By GlobeNewswire
Last update: Feb 20, 2025
BROOMFIELD, Colo., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the 2025 Spine Summit.
Read more at globenewswire.comNASDAQ:ACONW (12/1/2025, 8:00:00 PM)
0.0487
+0.01 (+21.75%)
NASDAQ:ACON (12/1/2025, 8:00:00 PM)
6.5
+0.24 (+3.83%)
Find more stocks in the Stock Screener


